Burkina Faso vs Poland: The number of people with susceptibility test result for rifampicin
Burkina Faso
3,042
in 2021
Poland
2,415
in 2021
Burkina Faso rank
40th
Poland rank
43rd
The number of people with susceptibility test result for rifampicin over time
- Burkina Faso
- Poland
How they compare
Burkina Faso currently reports 3,042 against 2,415 in Poland, a difference of 627.
That makes Burkina Faso's figure about 1.3 times Poland's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Poland ahead.
Burkina Faso ranks 40th and Poland ranks 43rd of 155 countries.
Across the 2 decades both report, Burkina Faso averaged higher in 1 and Poland in 1.
Head to head by decade
| Decade | Burkina Faso | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,230 | 3,229 | 1,999 | Poland |
| 2020s | 3,162 | 2,216 | 946 | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Burkina Faso or Poland?
- Burkina Faso, at 3,042 against 2,415 in Poland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Burkina Faso and Poland?
- 627, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Poland?
- 5 years are reported by both, from 2017 to 2021.
- How do Burkina Faso and Poland rank globally for the number of people with susceptibility test result for rifampicin?
- Burkina Faso ranks 40th and Poland ranks 43rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.